[HTML][HTML] Development of a lethal intranasal exposure model of Ebola virus in the cynomolgus macaque

KJ Alfson, LE Avena, G Worwa, R Carrion Jr, A Griffiths - Viruses, 2017 - mdpi.com
KJ Alfson, LE Avena, G Worwa, R Carrion Jr, A Griffiths
Viruses, 2017mdpi.com
Ebola virus (EBOV) is a filovirus that can cause Ebola virus disease (EVD). No approved
vaccines or therapies exist for filovirus infections, despite an urgent need. The development
and testing of effective countermeasures against EBOV requires use of animal models and a
thorough understanding of how the model aligns with EVD in humans. The majority of
published studies report outcomes of parenteral exposures for emulating needle stick
transmission. However, based on data from EVD outbreaks, close contact exposures to …
Ebola virus (EBOV) is a filovirus that can cause Ebola virus disease (EVD). No approved vaccines or therapies exist for filovirus infections, despite an urgent need. The development and testing of effective countermeasures against EBOV requires use of animal models and a thorough understanding of how the model aligns with EVD in humans. The majority of published studies report outcomes of parenteral exposures for emulating needle stick transmission. However, based on data from EVD outbreaks, close contact exposures to infected bodily fluid seems to be one of the primary routes of EBOV transmission. Thus, further work is needed to develop models that represent mucosal exposure. To characterize the outcome of mucosal exposure to EBOV, cynomolgus macaques were exposed to EBOV via intranasal (IN) route using the LMA® mucosal atomization device (LMA® MAD). For comparison, four non-human primates (NHPs) were exposed to EBOV via intramuscular (IM) route. This IN exposure model was uniformly lethal and correlated with a statistically significant delay in time to death when compared to exposure via the IM route. This more closely reflects the timeframes observed in human infections. An IN model of exposure offers an attractive alternative to other models as it can offer insight into the consequences of exposure via a mucosal surface and allows for screening countermeasures via a different exposure route.
MDPI